Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer
Journal of Neuro-Oncology · 2023
DOI: 10.1007/s11060-023-04520-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2023. Verfasst von Qian Miao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Circulating Tumor DNA, Meningeal Carcinomatosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
PURPOSE: Cerebrospinal fluid (CSF) has revealed the unique genetic characteristics of leptomeningeal metastasis (LM) from non-small cell lung cancer (NSCLC). However, the research in this area is still very limited. METHODS: Patients with LM from NSCLC (n = 80) were retrospectively analyzed. Circulating tumor DNA (ctDNA) in CSF was tested by next-generation sequencing (NGS), with paired extracranial tissue or plasma samples included for comparison. An independent non-LM cohort (n = 100) was also analyzed for comparative purposes. Clinical outcomes were compared with Kaplan-Meier log-rank test and Cox proportional hazards methodologies. RESULTS: An overwhelming 93.8% of patients carried druggable mutations in NSCLC LM, with EGFR (78.8%) being the most prevalent. Notably, 4 patients who tested negative for driver genes in extracranial samples surprisingly showed EGFR mutations in their CSF and subsequently benefited from targeted therapy. There was a clear difference in genetic profiles between CSF and extracranial samples, with CSF showing more driver gene detections, increased Copy Number Variations (CNVs), and varied resistance mechanisms among individuals. Abnormalities in cell-cycle regulatory molecules were highly enriched in LM (50.9% vs 31.0%, p = 0.017), and CDKN2A/2B deletions were identified as an independent poor prognostic factor for LM patients, with a significant reduction in median OS (p = 0.013), supported by multivariate analysis (HR 2.63, 95% CI 1.32-5.26, p = 0.006). CONCLUSIONS: CSF-based ctDNA analysis is crucial for detecting and characterizing genetic alterations in NSCLC LM. The distinct genetic profiles in CSF and extracranial tissues emphasize the need for personalized treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
- Geneplus-Beijing Institute, Beijing, China.
- Institute of Immunotherapy, Fujian Medical University, Fuzhou, China.
- Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. fjzllg133@fjzlhospital.com.
- Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, China. fjzllg133@fjzlhospital.com.
- Interdisciplinary Institute for Medical Engineering, Fuzhou University, Fuzhou, China. fjzllg133@fjzlhospital.com.
Förderung
- Natural Science Foundation of Fujian Province
- National Natural Science Foundation of China
Zitieren
APA
Miao, Q., Zheng, X., Li, L., Zheng, X., Zhang, L., Jiang, K., Wu, S., Wang, H., Wu, B., Xu, Y., Zhong, Q., Zou, Z., Zhang, Q., Yang, S., Li, Y., & Lin, G. (2023). Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-023-04520-2
Vancouver
Miao Q, Zheng X, Li L, Zheng X, Zhang L, Jiang K, et al. Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer. Journal of Neuro-Oncology. 2023. doi:10.1007/s11060-023-04520-2
BibTeX
@article{Miao2023,
author = {Miao, Qian and Zheng, Xinlong and Li, Lifeng and Zheng, Xiaobin and Zhang, Longfeng and Jiang, Kan and Wu, Shiwen and Wang, Haibo and Wu, Biao and Xu, Yiquan and Zhong, Qiaofeng and Zou, Zihua and Zhang, Qiuyu and Yang, Shanshan and Li, Yujing and Lin, Gen},
title = {Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer},
journal = {Journal of Neuro-Oncology},
year = {2023},
doi = {10.1007/s11060-023-04520-2}
}
EUVIMED